MedTrace Logo

Prognostic Impact of Organ Damage in STEMI Patients

NCT02800421 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 668

Last updated 2016-06-15

No results posted yet for this study

Summary

Besides contrast-induced acute kidney injury (CI-AKI), adscititious vital organ damage such as hypoxic liver injury (HLI) may affect the survival in patients with ST-elevation myocardial infarction (STEMI). Therefore, the investigator sought to evaluate the prognostic impact of CI-AKI and HLI in STEMI patients who underwent primary percutaneous coronary intervention (PCI).

Conditions

Sponsors & Collaborators

  • Inha University Hospital

    lead OTHER

Eligibility

Min Age
30 Years
Max Age
90 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2007-01-31
Primary Completion
2014-12-31
Completion
2015-07-31

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02800421 on ClinicalTrials.gov